Welcome to the research team webpage of Dr. Erin Gillespie. The Gillespie Lab is a dynamic team of research staff and trainees committed to advancing equitable, high-quality cancer care. The team is committed to finding innovative ways to provide patients with access to evidence-based cancer treatments that optimize quality of life. Current areas of focus include digital health, symptom science, hybrid implementation effectiveness trials, and quality improvement. Through cutting-edge implementation science and health services research, the Gillespie Lab strives to transform cancer care and improve outcomes for all people with cancer.
Associate Professor
Radiation Oncology
University of Washington / Fred Hutch Cancer Center
Dr. Gillespie has advanced training in implementation science, behavioral economics, and clinical trial design. Her research program focuses on pragmatic clinical trials to establish the effectiveness of new therapies and the development of strategies to improve access to evidence-based cancer care.
Research themes and currently open studies:
Current Lab Members:
The University of Washington Department of Radiation Oncology welcomes rotating medical students and has a medical student research fellowship. One month in person and two week virtual clerkships are available as well.
We welcome students both from the University of Washington and other schools of medicine. In the setting of the COVID-19 pandemic we are not offering in person visiting clerkships, but virtual clerkships are available.
Santos PMG, Silverwood S, Suneja G, Ford E, Thaker NG, Ostroff JS, Weiner BJ, Gillespie EF. “Dissemination and Implementation – A Primer for Accelerating “Time to Translation” in Radiation Oncology.” Int J Radiat Oncol Biol Phys. 2024 Dec 7:S0360-3016(24)03708-8. doi: 10.1016/j.ijrobp.2024.11.101. Epub ahead of print. PMID: 39653279.
Hung TKW, Verdini NP, Gilliland JL, Chimonas S, Cracchiolo JR, Li Y, Pfister DG, Gillespie EF. “When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians.” JCO Oncol Pract. 2024 Aug;20(8):1091-1102. doi: 10.1200/OP.23.00608. PMID: 38684040.
Gillespie EF, Santos PMG, Curry M, Salz T, Chakraborty N, Caron M, Fuchs HE, Ledesma Vicioso N, Mathis N, Kumar R, O’Brien C, Patel S, Guttmann DM, Ostroff JS, Salner AL, Panoff JE, McIntosh AF, Pfister DG, Vaynrub M, Yang JT, Lipitz-Snyderman A. “Implementation Strategies to Promote Short-Course Radiation for Bone Metastases.” JAMA Netw Open. 2024 May 1;7(5):e2411717. doi: 10.1001/jamanetworkopen.2024.11717. PMID: 38787561; PMCID: PMC11127116.
Rekha Narra L, Verdini N, Lapen K, Nipp R, Gillespie EF. “Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care.” Semin Radiat Oncol 2023 Oct. PMID: 37684065.
Verdini NP, Gelblum DY, Vertosick EA, Ostroff JS, Vickers AJ, Gomez DR, Gillespie EF. “Evaluating a Physician Audit and Feedback Intervention to Increase Clinical Trial Enrollment in Radiation Oncology in a Multisite Tertiary Cancer Center: A Randomized Study.” Int J Radiat Oncol Biol Phys. 2023 Sep 27. doi: 10.1016/j.ijrobp.2023.09.025. Epub ahead of print. PMID: 37769853.
Gillespie EF, Yang JC, Mathis NJ, Marine CB, White C, Zhang Z, Barker CA, Kotecha R, McIntosh A, Vaynrub M, Bartelstein MK, Mitchell A, Guttmann DM, Yerramilli D, Higginson DS, Yamada YJ, Kohutek ZA, Powell SN, Tsai J, Yang JT. “Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.” J Clin Oncol. 2023 Sep 25:JCO2300753. doi: 10.1200/JCO.23.00753. Epub ahead of print. PMID: 37748124.
Wahid KA, Lin D, Sahin O, Cislo M, Nelms BE, He R, Naser MA, Duke S, Sherer MV, Christodouleas JP, Mohamed ASR, Murphy JD, Fuller CD, Gillespie EF. “Large scale crowdsourced radiotherapy segmentations across a variety of cancer anatomic sites.” Sci Data. 2023 Mar 8. PMC10033824.
Patel MA*, Cha E*, Zakeri K, Braunstein LZ, McCormick B, Cahlon O, Powell SN, Morrow M, Khan AJ, Gillespie EF. “The Effect of Surgeon Referral and a Radiation Oncologist Productivity-Based Metric on Radiation Therapy Receipt Among Elderly Women With Early Stage Breast Cancer: Analysis From a Tertiary Cancer Network.” Advances Rad Onc. 2022 Oct 22. PMC9723302.
Korenstein D, Gillespie EF. “Audit and Feedback-Optimizing a Strategy to Reduce Low-Value Care.” JAMA. 2022 Sep 6. PMID: 36066538.
Zhang Y, Onochie I, Hipp E, Washington C, Cahlon O, Gomez D, Gillespie EF. “Prospective Clinical Evaluation of Integrating a Radiation Anatomist for Contouring in Routine Radiation Treatment Planning.” Advances Rad Onc. 2022 Jul 29. PMC9449753.
Ledesma Vicioso N, Lin D, Gomez DR, Kalman NS, Kotecha RR, Panoff JE, Mehta MP, Rutter CE, McIntosh A, Salner AL, Yang JT, Lee NY, Rimner A, Yamada Y, Zelefsky MJ, Ostroff JS, Diamond L, Mathis NJ, Cahlon O, Pfister DG, Zhang Z, Chino FL, Tsai J, Gillespie EF. “Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.” JCO OP. 2022 May. PMC10166438.
Zhang Y, Cha E, Lynch K, Gennarrelli R, Royce T, Brower J, Golden D, Chimonas S, Korenstein D, Gillespie EF. “Attitudes and Access to Resources and Strategies to Improve Radiotherapy Quality Among Radiation Oncologists: A Mixed Methods Study.” J Med Imaging Radiat Oncol. 2022 Jun 1. PMC9532345.
Lin D, Gomez, DR, Zhang YH, Genarelli R, Efstathiou JA, Barker CA, Gelblum D, Shah MK, Liberman L, Hirsch AE, Cahlon O, Gillespie EF. “Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for Junior Faculty: 1-Year Results of a Prospective Single Institution Initiative.” Int J Radiat Oncol Biol Phys. 2022 May 26. PMC9396442.
Gillespie EF, Golden DW. “The Art and Science of Mentorship”. ASTRONews Summer 2021. Reprinted by ASCO Daily News (GI Symposium Jan 2022; GU Symposium Feb 2022).